FindTrial
Sign In

E22.0

2 trials

Sponsors

Faculdade de Medicina - Universidade Federal do Rio de Janeiro (UFRJ), Instituto Estadual do Cerebro Paulo Niemeyer

Conditions

AcromegalyStudy conducted: women with disease: Acromegaly. Target population: Female (childbearing age), volunteers of the intervention female with uncontrolled Acromegaly. Medicine: formulation oral of ethynil estradiol 0.03mg + levonorgestrel 0.15mg. Acromegaly, Growth Hormone-Secreting Pituitary Adenoma, pituitary disease, pituitary neoplasms.

Phase 2

Study to evaluate the response to treatment with the medication pasireotide LAR and the expression of the substances AIP and miR-34a in patients with acromegaly
Active, not recruitingRBR-29grfm
Faculdade de Medicina - Universidade Federal do Rio de Janeiro (UFRJ)Acromegaly
Start: 2016-06-01Updated: 2025-10-27
Oral Estrogen use in treatment of women with Acromegaly
RecruitingRBR-4n5mkh
Instituto Estadual do Cerebro Paulo NiemeyerStudy conducted: women with disease: Acromegaly. Target population: Female (childbearing age), volunteers of the intervention female with uncontrolled Acromegaly. Medicine: formulation oral of ethynil estradiol 0.03mg + levonorgestrel 0.15mg. Acromegaly, Growth Hormone-Secreting Pituitary Adenoma, pituitary disease, pituitary neoplasms.
Start: 2017-09-29Updated: 2025-10-27